Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07531043 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Safety of FID 123472 Ophthalmic Solution for Ocular Redness in Adults

StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 17 wordsv5
  2. Primary endpoint(s) modifiedv4 Show 4 more changesShow less
    • Enrollment target: 240 to 230
    • Eligibility criteria shortened, about 51 words
    • Secondary endpoints revised (2)
    • Study title shortened, about 5 words
  3. Primary and study completion moved earlier from Nov 2027 to Feb 2027v3
  4. Secondary endpoints: details revised at 2 of 2 entriesv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Alcon Research
30 trials monitored
See 3 trials at risk
The purpose of this study is to evaluate the efficacy and safety of an investigational ophthalmic solution in adults with ocular redness due to minor eye irritations.
Trial Details
NCT Number NCT07531043
Lead Sponsor Alcon Research
Conditions
(from sponsor)		 Ocular Hyperemia
Enrollment 230 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov